Product Information
COSENTYX SENSOREADY 150 MG/ML PEN is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $7854.3190 per ML under NDC 00078063968. Its NADAC has been published 118 times since May 22, 2024.
Strength
150 mg/mL
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078063968
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
SECUKINUMABApproval Type
Biologic (BLA)
FDA Application
BLA125504On Market Since
1/21/2015
Pharmacological Classes
Price Statistics
The NADAC for COSENTYX SENSOREADY 150 MG/ML PEN has been published 118 times since May 22, 2024, and over the history we have for it it has risen 9.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7854.3190 per ML |
|---|---|
| All-time high | $7874.0281 (May 13, 2026) |
| All-time low | $7198.5482 (Aug 21, 2024) |
| 52-week high | $7874.0281 |
| 52-week low | $7358.9048 |
| Median price | $7369.5275 |
| Average price | $7463.4807 |
| Largest weekly change | +7.0% (Jan 14, 2026) |
| Weeks tracked | 118 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of COSENTYX SENSOREADY 150 MG/ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for COSENTYX SENSOREADY 150 MG/ML PEN, manufactured by Novartis Pharmaceuticals Corporation, is $7854.3190 per ML (NDC 00078063968), effective Aug 19, 2026.
How has the price of COSENTYX SENSOREADY 150 MG/ML PEN changed over time?
Over the history we have for it, the NADAC for COSENTYX SENSOREADY 150 MG/ML PEN has risen 9.0%. It has been tracked across 118 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for COSENTYX SENSOREADY 150 MG/ML PEN?
Since May 22, 2024, the NADAC for COSENTYX SENSOREADY 150 MG/ML PEN has ranged from a low of $7198.5482 (Aug 21, 2024) to a high of $7874.0281 (May 13, 2026), with a median of $7369.5275 per ML.
Are there cheaper alternatives to COSENTYX SENSOREADY 150 MG/ML PEN?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES, is $3924.3531 per ML — about 50% below COSENTYX SENSOREADY 150 MG/ML PEN.
Who manufactures COSENTYX SENSOREADY 150 MG/ML PEN?
COSENTYX SENSOREADY 150 MG/ML PEN (NDC 00078063968) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.